Cullen/Frost Bankers’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$99.7K Buy
2,337
+10
+0.4% +$447 ﹤0.01% 725
2026
Q1
$112K Sell
2,327
-78
-3% -$3.64K ﹤0.01% 655
2025
Q4
$117K Buy
2,405
+114
+5% +$5.65K ﹤0.01% 657
2025
Q3
$108K Buy
2,291
+826
+56% +$39.9K ﹤0.01% 634
2025
Q2
$70.8K Sell
1,465
-467
-24% -$23.9K ﹤0.01% 684
2025
Q1
$107K Buy
1,932
+474
+33% +$25.7K ﹤0.01% 596
2024
Q4
$70.3K Buy
1,458
+74
+5% +$3.76K ﹤0.01% 658
2024
Q3
$79.8K Buy
1,384
+93
+7% +$5.02K ﹤0.01% 641
2024
Q2
$62.6K Buy
1,291
+41
+3% +$1.98K ﹤0.01% 648
2024
Q1
$60.8K Hold
1,250
﹤0.01% 630
2023
Q4
$62.2K Sell
1,250
-223
-15% -$10.9K ﹤0.01% 632
2023
Q3
$79K Buy
1,473
+104
+8% +$5.54K ﹤0.01% 648
2023
Q2
$73.8K Buy
1,369
+187
+16% +$10.1K ﹤0.01% 668
2023
Q1
$64.3K Buy
1,182
+182
+18% +$8.85K ﹤0.01% 680
2022
Q4
$48.4K Sell
1,000
-911
-48% -$40K ﹤0.01% 707
2022
Q3
$73K Buy
1,911
+545
+40% +$24.3K ﹤0.01% 646
2022
Q2
$68K Buy
1,366
+337
+33% +$17.9K ﹤0.01% 657
2022
Q1
$53K Hold
1,029
﹤0.01% 735
2021
Q4
$52K Sell
1,029
-702
-41% -$34.7K ﹤0.01% 745
2021
Q3
$83K Hold
1,731
﹤0.01% 653
2021
Q2
$91K Hold
1,731
﹤0.01% 658
2021
Q1
$86K Sell
1,731
-7,369
-81% -$354K ﹤0.01% 632
2020
Q4
$442K Sell
9,100
-50
-0.5% -$2.47K 0.01% 373
2020
Q3
$459K Buy
9,150
+7,419
+429% +$382K 0.01% 349
2020
Q2
$88K Buy
1,731
+881
+104% +$42.8K ﹤0.01% 558
2020
Q1
$37K Buy
850
+119
+16% +$5.69K ﹤0.01% 542
2019
Q4
$37K Hold
731
﹤0.01% 655
2019
Q3
$34K Sell
731
-155
-17% -$6.68K ﹤0.01% 629
2019
Q2
$39K Buy
886
+89
+11% +$3.79K ﹤0.01% 597
2019
Q1
$35K Buy
+797
New +$34.1K ﹤0.01% 610
2016
Q3
Sell
-7,947
Closed -$332K 375
2016
Q2
$332K Sell
7,947
-162
-2% -$6.64K 0.01% 307
2016
Q1
$325K Buy
8,109
+185
+2% +$7.43K 0.01% 311
2015
Q4
$338K Sell
7,924
-333
-4% -$15.3K 0.01% 302
2015
Q3
$392K Buy
8,257
+1,199
+17% +$61K 0.02% 295
2015
Q2
$349K Hold
7,058
0.01% 322
2015
Q1
$349K Sell
7,058
-442
-6% -$21.1K 0.01% 324
2014
Q4
$342K Buy
7,500
+100
+1% +$4.85K 0.01% 335
2014
Q3
$417K Sell
7,400
-234
-3% -$12.6K 0.02% 313
2014
Q2
$406K Sell
7,634
-651
-8% -$34.6K 0.02% 311
2014
Q1
$434K Buy
8,285
+3,340
+68% +$169K 0.02% 296
2013
Q4
$265K Buy
4,945
+504
+11% +$26K 0.01% 334
2013
Q3
$225K Sell
4,441
-330
-7% -$16.8K 0.01% 349
2013
Q2
$245K Buy
+4,771
New +$254K 0.01% 333

Other funds holding SNY

Cullen/Frost Bankers's SNY Position: Q2 2026 in Review

Cullen/Frost Bankers increased its Sanofi (SNY) stake by 0.43% in Q2 2026, buying an estimated $447 and bringing the position to 2,337 shares worth $99.7K. The position accounts for ﹤0.01% of the portfolio, ranked #725.

Cullen/Frost Bankers first reported a position in SNY in Q2 2013 and has held it in 43 quarters since. The position peaked at $459K in Q3 2020. 270 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Cullen/Frost Bankers held 2,337 shares of Sanofi worth $99.7K as of Q2 2026.
  • Cullen/Frost Bankers bought 10 Sanofi shares in Q2 2026, an estimated $447.
  • Sanofi made up ﹤0.01% of Cullen/Frost Bankers's portfolio in Q2 2026, its #725 holding.
  • Cullen/Frost Bankers first reported a position in Sanofi in Q2 2013 and has held it in 43 quarters since.
  • Cullen/Frost Bankers's Sanofi position peaked at $459K in Q3 2020.
  • 270 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.